JIANG SHISONG has a total of 18 patent applications. Its first patent ever was published in 2007. It filed its patents most often in China, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are A & G PHARMACEUTICALS INC, DEUTSCHES ZENTRUM FUER NEURODEGENERATIVE ERKRANKUNGEN E V DZNE and MORPHOTEK INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 8 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Syringes | |
#7 | Horticulture | |
#8 | Planting | |
#9 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Jiang Shisong | 18 |
#2 | Lu Wenshu | 11 |
#3 | Yu Zhanru | 1 |
#4 | Ruprecht Ruth | 1 |
#5 | Ding Hanghai | 1 |
#6 | Lu Chao | 1 |
#7 | Xia Xiaobing | 1 |
#8 | Ying Songmin | 1 |
Publication | Filing date | Title |
---|---|---|
CN110613838A | Polypeptide for enhancing cell permeability and application thereof | |
CN107787739A | A kind of method for preventing and treating jujube witches broom | |
US2017340751A1 | Artificial multi-antigen fusion protein and preparation and use thereof | |
CN106800597A | It is a kind of to neutralize the albumen and its application for promoting programmed cell death (PCD) antibody | |
CN106349388A | Procedural cell necrosis promoting antibody and application thereof | |
CN103143039A | Ointment for haemorrhoid physical sign | |
CN102961760A | Overlaping peptide taken as reagent for preparing skin tests and detecting specific cellular immune and application | |
CN106046144A | Apoptosis or necrosis related TNF (Tumor Necrosis Factor) alpha oligopeptide and application thereof |